$SCLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SCICLONE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SCICLONE PHARMACEUTICALS INC. Get notifications about new insider transactions in SCICLONE PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 3,000 | 0 | 157,000 | |
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 25,000 | 0 | 160,000 | |
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 12,500 | 0 | 185,000 | |
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | S | 10.75 | 25,000 | 268,750 | 0 | 25 K to 0 (-100.00 %) |
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | S | 10.75 | 12,500 | 134,375 | 25,000 | 37.5 K to 25 K (-33.33 %) |
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | S | 10.75 | 3,000 | 32,250 | 37,500 | 40.5 K to 37.5 K (-7.41 %) |
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 3,000 | 0 | 40,500 | 37.5 K to 40.5 K (+8.00 %) |
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 25,000 | 0 | 37,500 | 12.5 K to 37.5 K (+200.00 %) |
Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 19,956 | 70,844 | 97,654 | |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 19,700 | 69,935 | 117,610 | |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 11.00 | 19,956 | 219,608 | 93,299 | 113.3 K to 93.3 K (-17.62 %) |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 19,956 | 70,844 | 113,255 | 93.3 K to 113.3 K (+21.39 %) |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.03 | 19,700 | 197,524 | 93,299 | 113 K to 93.3 K (-17.43 %) |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 19,700 | 69,935 | 112,999 | 93.3 K to 113 K (+21.11 %) |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | A | 10.90 | 30,000 | 327,000 | 30,000 | |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Option Exercise | A | 10.90 | 30,000 | 327,000 | 30,000 | |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 10.90 | 30,000 | 327,000 | 30,000 | |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | Li Simon | Director | Option Exercise | A | 10.90 | 30,000 | 327,000 | 30,000 | |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | A | 10.90 | 30,000 | 327,000 | 30,000 | |
Jun 06 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 5,500 | 19,525 | 137,310 | |
Jun 06 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 4,800 | 17,040 | 142,810 | |
Jun 06 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 5,500 | 55,000 | 93,299 | 98.8 K to 93.3 K (-5.57 %) |
Jun 06 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 5,500 | 19,525 | 98,799 | 93.3 K to 98.8 K (+5.90 %) |
Jun 06 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 4,800 | 48,000 | 93,299 | 98.1 K to 93.3 K (-4.89 %) |
Jun 06 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 4,800 | 17,040 | 98,099 | 93.3 K to 98.1 K (+5.14 %) |
May 25 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 6,298 | 22,358 | 147,610 | |
May 25 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 15,166 | 53,839 | 153,908 | |
May 25 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.36 | 6,298 | 58,975 | 92,526 | 98.8 K to 92.5 K (-6.37 %) |
May 25 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 6,298 | 22,358 | 98,824 | 92.5 K to 98.8 K (+6.81 %) |
May 25 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.31 | 15,166 | 141,155 | 92,526 | 107.7 K to 92.5 K (-14.08 %) |
May 25 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 15,166 | 53,839 | 107,692 | 92.5 K to 107.7 K (+16.39 %) |
May 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 18,536 | 65,803 | 169,074 | |
May 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.44 | 18,536 | 175,026 | 92,526 | 111.1 K to 92.5 K (-16.69 %) |
May 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 18,536 | 65,803 | 111,062 | 92.5 K to 111.1 K (+20.03 %) |
May 15 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 18,226 | 64,702 | 187,610 | |
May 15 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 18,226 | 182,315 | 92,526 | 110.8 K to 92.5 K (-16.46 %) |
May 15 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 18,226 | 64,702 | 110,752 | 92.5 K to 110.8 K (+19.70 %) |
May 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 164 | 582 | 205,836 | |
May 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 164 | 1,640 | 92,526 | 92.7 K to 92.5 K (-0.18 %) |
May 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 164 | 582 | 92,690 | 92.5 K to 92.7 K (+0.18 %) |
May 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 164 | 582 | 205,836 | |
May 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 164 | 1,640 | 92,526 | 92.7 K to 92.5 K (-0.18 %) |
May 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 164 | 582 | 92,690 | 92.5 K to 92.7 K (+0.18 %) |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 200 | 710 | 206,000 | |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 2,800 | 9,940 | 206,200 | |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 1,400 | 4,970 | 209,000 | |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 200 | 2,000 | 92,526 | 92.7 K to 92.5 K (-0.22 %) |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 200 | 710 | 92,726 | 92.5 K to 92.7 K (+0.22 %) |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.01 | 2,800 | 28,023 | 92,526 | 95.3 K to 92.5 K (-2.94 %) |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 2,800 | 9,940 | 95,326 | 92.5 K to 95.3 K (+3.03 %) |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 1,400 | 14,000 | 92,526 | 93.9 K to 92.5 K (-1.49 %) |
Apr 28 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 1,400 | 4,970 | 93,926 | 92.5 K to 93.9 K (+1.51 %) |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 12,160 | 43,168 | 210,400 | |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 16,162 | 57,375 | 222,560 | |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 11,678 | 41,457 | 238,722 | |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.64 | 12,160 | 117,228 | 92,526 | 104.7 K to 92.5 K (-11.62 %) |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 12,160 | 43,168 | 104,686 | 92.5 K to 104.7 K (+13.14 %) |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.47 | 16,162 | 153,130 | 92,526 | 108.7 K to 92.5 K (-14.87 %) |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 16,162 | 57,375 | 108,688 | 92.5 K to 108.7 K (+17.47 %) |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.60 | 11,678 | 112,111 | 92,526 | 104.2 K to 92.5 K (-11.21 %) |
Apr 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 11,678 | 41,457 | 104,204 | 92.5 K to 104.2 K (+12.62 %) |
Mar 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 9,662 | 34,300 | 250,400 | |
Mar 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 30,338 | 107,700 | 260,062 | |
Mar 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.33 | 9,662 | 90,126 | 92,526 | 102.2 K to 92.5 K (-9.46 %) |
Mar 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 9,662 | 34,300 | 102,188 | 92.5 K to 102.2 K (+10.44 %) |
Mar 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.51 | 30,338 | 288,496 | 92,526 | 122.9 K to 92.5 K (-24.69 %) |
Mar 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 30,338 | 107,700 | 122,864 | 92.5 K to 122.9 K (+32.79 %) |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | M | 0.00 | 1,250 | 0 | 22,500 | |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Buy | M | 0.00 | 1,250 | 0 | 13,513 | 12.3 K to 13.5 K (+10.19 %) |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 0.00 | 1,000 | 0 | 19,000 | |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | S | 9.60 | 1,000 | 9,600 | 0 | 1,000 to 0 (-100.00 %) |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 3,000 | 0 | 122,500 | |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | S | 9.60 | 3,000 | 28,800 | 0 | 3 K to 0 (-100.00 %) |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 190,000 | |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 0.00 | 5,000 | 0 | 92,526 | 87.5 K to 92.5 K (+5.71 %) |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 3,000 | 0 | 122,500 | |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Payment of Exercise | F | 9.60 | 1,128 | 10,829 | 1,872 | 3 K to 1.9 K (-37.60 %) |
Mar 17 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | A | 9.65 | 24,426 | 235,711 | 24,426 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | A | 9.65 | 10,574 | 102,039 | 10,574 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | A | 0.00 | 5,000 | 0 | 23,750 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | A | 9.65 | 21,000 | 202,650 | 21,000 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | A | 0.00 | 3,000 | 0 | 20,000 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | A | 9.65 | 84,000 | 810,600 | 84,000 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | A | 0.00 | 12,000 | 0 | 125,500 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | A | 9.65 | 73,349 | 707,818 | 73,349 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | A | 9.65 | 10,651 | 102,782 | 10,651 | |
Mar 09 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | A | 0.00 | 12,000 | 0 | 125,500 | |
Mar 08 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | A | 9.65 | 129,157 | 1,246,365 | 129,157 | |
Mar 08 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | A | 9.65 | 10,843 | 104,635 | 10,843 | |
Mar 08 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | A | 0.00 | 20,000 | 0 | 345,000 | |
Mar 08 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 3,087 | 10,959 | 290,400 | |
Mar 08 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.30 | 3,087 | 31,787 | 87,526 | 90.6 K to 87.5 K (-3.41 %) |
Mar 08 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 3,087 | 10,959 | 90,613 | 87.5 K to 90.6 K (+3.53 %) |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 6,513 | 23,121 | 293,487 | |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 6,783 | 7,326 | 0 | |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 4,417 | 4,770 | 6,783 | |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 9,200 | 9,936 | 11,200 | |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.03 | 6,513 | 65,304 | 87,526 | 94 K to 87.5 K (-6.93 %) |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 6,513 | 23,121 | 94,039 | 87.5 K to 94 K (+7.44 %) |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.03 | 6,783 | 68,011 | 87,526 | 94.3 K to 87.5 K (-7.19 %) |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 6,783 | 7,326 | 94,309 | 87.5 K to 94.3 K (+7.75 %) |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.01 | 4,417 | 44,198 | 87,526 | 91.9 K to 87.5 K (-4.80 %) |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 4,417 | 4,770 | 91,943 | 87.5 K to 91.9 K (+5.05 %) |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 9,200 | 92,010 | 87,526 | 96.7 K to 87.5 K (-9.51 %) |
Mar 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 9,200 | 9,936 | 96,726 | 87.5 K to 96.7 K (+10.51 %) |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | M | 2.61 | 12,700 | 33,147 | 0 | |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Buy | M | 2.61 | 12,700 | 33,147 | 135,000 | 122.3 K to 135 K (+10.38 %) |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 9,800 | 10,584 | 21,223 | |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 9,201 | 9,937 | 31,023 | |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 20,176 | 21,790 | 40,224 | |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.76 | 9,800 | 95,609 | 86,784 | 96.6 K to 86.8 K (-10.15 %) |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 9,800 | 10,584 | 96,584 | 86.8 K to 96.6 K (+11.29 %) |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.86 | 9,201 | 90,714 | 86,784 | 96 K to 86.8 K (-9.59 %) |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 9,201 | 9,937 | 95,985 | 86.8 K to 96 K (+10.60 %) |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.86 | 20,176 | 198,956 | 86,784 | 107 K to 86.8 K (-18.86 %) |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 20,176 | 21,790 | 106,960 | 86.8 K to 107 K (+23.25 %) |
Feb 17 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | M | 2.61 | 17,300 | 45,153 | 12,700 | |
Feb 17 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Buy | M | 2.61 | 17,300 | 45,153 | 122,300 | 105 K to 122.3 K (+16.48 %) |
Jan 27 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 8,868 | 9,577 | 60,400 | |
Jan 27 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.54 | 8,868 | 93,439 | 86,784 | 95.7 K to 86.8 K (-9.27 %) |
Jan 27 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 8,868 | 9,577 | 95,652 | 86.8 K to 95.7 K (+10.22 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 4,793 | 5,176 | 69,268 | |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 21,132 | 22,823 | 74,061 | |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 4,807 | 5,192 | 95,193 | |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 18,000 | 32,580 | 0 | |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 12,400 | 22,444 | 18,000 | |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.41 | 4,793 | 49,887 | 86,784 | 91.6 K to 86.8 K (-5.23 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 4,793 | 5,176 | 91,577 | 86.8 K to 91.6 K (+5.52 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.51 | 21,132 | 222,099 | 86,784 | 107.9 K to 86.8 K (-19.58 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 21,132 | 22,823 | 107,916 | 86.8 K to 107.9 K (+24.35 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.41 | 4,807 | 50,059 | 86,784 | 91.6 K to 86.8 K (-5.25 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 4,807 | 5,192 | 91,591 | 86.8 K to 91.6 K (+5.54 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.41 | 18,000 | 187,448 | 86,784 | 104.8 K to 86.8 K (-17.18 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 18,000 | 32,580 | 104,784 | 86.8 K to 104.8 K (+20.74 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.38 | 12,400 | 128,741 | 86,784 | 99.2 K to 86.8 K (-12.50 %) |
Jan 24 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 12,400 | 22,444 | 99,184 | 86.8 K to 99.2 K (+14.29 %) |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 9,200 | 16,652 | 30,400 | |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 100 | 181 | 39,600 | |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 300 | 543 | 39,700 | |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 11.02 | 9,200 | 101,388 | 86,784 | 96 K to 86.8 K (-9.58 %) |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 9,200 | 16,652 | 95,984 | 86.8 K to 96 K (+10.60 %) |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 11.00 | 100 | 1,100 | 86,784 | 86.9 K to 86.8 K (-0.12 %) |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 100 | 181 | 86,884 | 86.8 K to 86.9 K (+0.12 %) |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 11.00 | 300 | 3,300 | 86,784 | 87.1 K to 86.8 K (-0.34 %) |
Jan 05 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 300 | 543 | 87,084 | 86.8 K to 87.1 K (+0.35 %) |
Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 6,901 | 12,491 | 40,000 |